These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 20698800

  • 1. Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas.
    Garcia-Martin E, Idoipe M, Gil LM, Pueyo V, Alfaro J, Pablo LE, Zubiri ML, Fernandez J.
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):373-9. PubMed ID: 20698800
    [Abstract] [Full Text] [Related]

  • 2. Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma.
    Garcia-Martin E, Gil-Arribas LM, Idoipe M, Alfaro J, Pueyo V, Pablo LE, Fernandez FJ.
    Br J Ophthalmol; 2011 Oct; 95(10):1393-6. PubMed ID: 21242584
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma.
    Blasi MA, Giammaria D, Balestrazzi E.
    Am J Ophthalmol; 2005 Dec; 140(6):1136-9. PubMed ID: 16376667
    [Abstract] [Full Text] [Related]

  • 6. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
    Vidal D, Matías-Guiu X, Alomar A.
    Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
    [Abstract] [Full Text] [Related]

  • 7. Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area.
    Karabulut GO, Kaynak P, Ozturker C, Fazil K, Ocak OB, Taskapılı M.
    Indian J Ophthalmol; 2017 Jan; 65(1):48-51. PubMed ID: 28300740
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up.
    Schiessl C, Wolber C, Tauber M, Offner F, Strohal R.
    J Drugs Dermatol; 2007 May; 6(5):507-13. PubMed ID: 17679185
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas.
    Marks R, Owens M, Walters SA, Australian Multi-Centre Trial Group.
    Arch Dermatol; 2004 Oct; 140(10):1284-5. PubMed ID: 15492200
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.